GME_18x18.jpg
Global Oncology Antibody Drug Conjugates Market Size
April 28, 2022 09:15 ET | Global Market Estimates
Brooklyn, New York, April 28, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is...
Elucida Oncology Logo.jpg
Elucida Oncology’s Lead Clinical Candidate ELU001 to Be Featured in Two Abstracts at the American Association for Cancer Research Annual Meeting
April 04, 2022 10:00 ET | Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., April 04, 2022 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company developing the next frontier in targeted cancer therapy, announced today two...
$5.9 Billion Worldwide Antibody Drug Conjugates Industry to 2031 - Identify Growth Segments for Investment
March 22, 2022 05:28 ET | Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2022: By Type, By Application, By Product, By Technology, By End-User" report has been added to...
22157.jpg
Global Cancer Antibody Drug Conjugate Markets, Forecast to 2028 - Sales Trends; Clinical Insights; Dosage, Price & Patent Insights; Quarterly & Yearly Drug Sales; Competitive Landscape and More
March 02, 2022 06:13 ET | Research and Markets
Dublin, March 02, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Antibody Drug Conjugate Market, Drug Sales, Price, & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...
Vantage Market Research.png
Antibody Drug Conjugates (ADCs) Market Size to Reach USD 13.17 Billion by 2028 - Powered by Approval for Biologics License Applications – Vantage Market Research
February 15, 2022 04:39 ET | Vantage Market Research
WASHINGTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Antibody Drug Conjugates (ADCS) Market finds that granted accelerated approval for biologics...
logo.jpg
Genmab and Synaffix Enter into License Agreement for ADC Technology
January 04, 2022 09:00 ET | Genmab A/S
Media Release Synaffix to provide access to proprietary antibody-drug conjugate (ADC) technologiesGenmab secures rights for conducting research on ADCs against multiple drug targets with options for...
22157.jpg
Global Antibody Drug Conjugates Contract Manufacturing Market (2021 to 2028) - Featuring Lonza, Catalent and Siegfried Among Others
November 02, 2021 08:48 ET | Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Contract Manufacturing Market Size, Share & Trends Analysis Report By Condition (Myeloma, Lymphoma, Breast Cancer), By...
22157.jpg
Global Antibody Drug Conjugates Market Research 2021 Featuring Major Players - Bayer, Concortis Biotherapeutics, F. Hoffman-La Roche, Immunomedics, and Oxford BioTherapeutics
October 20, 2021 09:23 ET | Research and Markets
Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Insights on the Antibody Drug Conjugates Global Market to 2030 - Featuring 6 Dimensions Capital, AbbVie and ABL Bio Among Others
October 08, 2021 05:58 ET | Research and Markets
Dublin, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market by Indication, Linker, Payload, Target Antigens and Geography: Industry Trends and Global Forecasts, 2021-2030" report...
22157.jpg
Worldwide Oncology Pharmaceuticals Industry to 2026 - Robust Approval of Oncology Pharmaceuticals is Driving Growth
October 06, 2021 07:13 ET | Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Pharmaceuticals Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for oncology...